FIGURE

Fig. 2

ID
ZDB-FIG-231108-43
Publication
Chang et al., 2023 - Zebrafish facilitate non-alcoholic fatty liver disease research: Tools, models and applications
Other Figures
All Figure Page
Back to All Figure Page
Fig. 2

Pathological mechanisms of NAFLD and main models in zebrafish. Possible pathological mechanisms of steatosis in NAFLD induced by diets, insulin resistance, pathogens and hepatoxic drugs, and the effects of mitochondrial dysfunction, endoplasmic reticulum stress and inflammatory cell infiltration which lead to inflammation, fibrosis and apoptosis in hepatocytes. The diet models, transgenic and mutation models involved are shown in the figure. ACC, acetyl-CoA carboxylase; CHOP, CCAAT/enhancer-binding protein homologous protein; CM, chylomicron; DAGs, diacylglycerols; DNL, de novo lipogenesis; EDCs, endocrine-disrupting chemicals; ER, endoplasmic reticulum; FFA, free fatty acid; FAS, fatty acid synthase; FXR, farnesoid X receptor; HBV, hepatitis B virus; HSC, hepatic stellate cell; JAK-STAT, Janus kinase/signal transducer and activator of transcription; JUNK, Jun amino-terminal kinase; LPCs, lysophosphatidylcholines; LXR, liver X receptors; MO, morpholino; mTOR, mechanistic target of rapamycin; PPAR, peroxisome proliferators-activated receptors; ROS, reactive oxygen species; SCD, stearoyl-CoA desaturase; SREBP-1C, sterol regulatory element binding protein 1c; TG, triglyceride; UPR, unfolded protein response; VLDL, very low-density lipoprotein.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Liver Int.